It is a pharma private limited company based in New Delhi, Delhi, India, established in 1991.
1991 | New Delhi, Delhi, India | ActiveRishabh Drugs Private Limited, a active private limited company, was established on 09 August 1991 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U33125DL1991PTC045326. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.71 M.
It upholds a compliant status. Its leadership includes Shivani Jain (Director), Raj Pal Sharma (Director), Pradeep Kumar Jain (Director). Past directors included Naresh Chand Jain, Dinesh Kumar Nagpal, Narender Jain. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-110, 3Rd Floor Malvia Nagar, New Delhi, Delhi, 110017.
U33125DL1991PTC045326
045326
09 August 1991
₹1.50 M
₹0.71 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rishabh Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivani Jain | Director | 28 Jan 2019 | Current |
| Raj Pal Sharma | Director | 03 Oct 1991 | Current |
| Pradeep Kumar Jain | Director | 03 Oct 1991 | Current |
| Apra Jain | Director | 03 Oct 1991 | Current |
| Rahul Jain | Director | 02 Aug 2016 | Current |
| Surender Kumar Jain | Director | 03 Oct 1991 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Apr 2019 | Past |
| Pramod Abcsdd | Director | 15 Jun 2018 | Past |
| Pramod Abcsdd | Director | 08 Mar 2013 | Past |
| Pramod Abcsdd | Director | 02 Aug 2016 | Past |
| Pramod Abcsdd | Director | 02 Aug 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rishabh Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 254.56% increase. The company also saw a substantial fall in profitability, with a 77.19% decrease in profit. The company's net worth moved up by a moderate rise of 9.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rishabh Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rishabh Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rishabh Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rishabh Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rishabh Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Rishabh Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Shivani Jain was appointed as a Director was appointed as a Director on 28 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
Rahul Jain was appointed as a Director was appointed as a Director on 02 Aug 2016 & has been associated with this company since 9 years 3 months . was recorded as a recent event.
The activity Vartika Jain was appointed as a Director was appointed as a Director on 02 Aug 2016 & has been associated with this company since 9 years 3 months . was completed.
Raj Pal Sharma was appointed as a Director was appointed as a Director on 03 Oct 1991 & has been associated with this company since 34 years 1 month . was recorded as a recent event.
The CIN of Rishabh Drugs Private Limited is U33125DL1991PTC045326.
Rishabh Drugs Private Limited is headquartered at B-110, 3Rd Floor Malvia Nagar, New Delhi, Delhi, 110017.
Rishabh Drugs Private Limited was incorporated on 09 August 1991.
The current directors of Rishabh Drugs Private Limited are
The primary industry of Rishabh Drugs Private Limited is Manufacturing.
Rishabh Drugs Private Limited is unlisted.
The authorized capital of Rishabh Drugs Private Limited is ₹1.50 M, and the paid-up capital is ₹0.71 M.
The compliance status of Rishabh Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX